title: How do we get to meaningful use?
authors.affiliation: National Council for Prescription Drug Programs, USA.
authors.forename: John
authors.initials: J
authors.lastname: Klimek
authors.forename: Nick
authors.initials: N
authors.lastname: van Terheyden
authors.forename: Paul
authors.initials: P
authors.lastname: Brient
authors.forename: Cheryl
authors.initials: C
authors.lastname: Servais
authors.forename: Ellen
authors.initials: E
authors.lastname: Bellini
authors.forename: Robert
authors.initials: R
authors.lastname: Hitchcock
authors.forename: Laurens
authors.initials: L
authors.lastname: van der Tang
authors.forename: Bruce
authors.initials: B
authors.lastname: Wallace
authors.forename: Jonathan
authors.initials: J
authors.lastname: Hare
authors.forename: Rod
authors.initials: R
authors.lastname: Walker
authors.forename: Laurie
authors.initials: L
authors.lastname: Eldridge-Shanaman
authors.forename: Todd
authors.initials: T
authors.lastname: Kelly
mesh_terms: D057171:American Recovery and Reinvestment Act; D014487:Centers for Medicare and Medicaid Services, U.S.; D004059:Diffusion of Innovation; D057286:Electronic Health Records; D008490:Medical Informatics; D012052:Reimbursement, Incentive / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States